Cardiac surgery increases serum concentrations of adipocyte fatty acid-binding protein and its mRNA expression in circulating monocytes but not in adipose tissue

Physiological Research

Volumn 63, Issue 1, 2014, Pages 83-94

  Kotulak, T ^a   Drapalova, J ^b   Lips, M ^b   Lacinova, Z ^b   Kramar, P ^a   Riha, H ^a   Netuka, I ^a,c   Maly, J ^a   Blaha, J ^b   Lindner, J ^c   Svacina, S ^b   Mraz, M ^b   Haluzik, M ^b  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Adipocyte fatty acid binding protein; Adipose tissue; Cardiac surgery; Insulin resistance; Skeletal muscle

Indexed keywords

BIOLOGICAL MARKER; FABP4 PROTEIN, HUMAN; FATTY ACID BINDING PROTEIN; MESSENGER RNA;

ADIPOSE TISSUE; AGED; BIOSYNTHESIS; BLOOD; GENE EXPRESSION REGULATION; HEART SURGERY; HUMAN; MALE; METABOLISM; MIDDLE AGED; MONOCYTE;

ADIPOSE TISSUE; AGED; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; FATTY ACID-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; MONOCYTES; RNA, MESSENGER;

EID: 84896993228     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. AGARDH HE, FOLKERSEN L, EKSTRAND J, MARCUS D, SWEDENBORG J, HEDIN U, GABRIELSEN A, PAULSSON-BERNE G: Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis. J Intern Med 269: 200-210, 2011.
2. ANDRéS CEREZO L, KUKLOVá M, HULEJOVá H, VERNEROVá Z, PEŠáKOVá V, PECHA O, VEIGL D, HALUZíK M, PAVELKA K, VENCOVSKý J, SENOLT L: The level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels. Cytokine 64: 441-447, 2013.
3. BAO Y, LU Z, ZHOU M, LI H, WANG Y, GAO M, WEI M, JIA W: Serum levels of adipocyte fatty acid binding protein are associated with the severity of coronary artery disease in chinese women. PLoS One 28: 19115, 2011.
4. BAXA CA, SHA RS, BUELT MK, SMITH AJ, MATARESE V, CHINANDER LL, BOUNDY KL, BERNLOHR DA: Human adipocyte lipid-binding protein purification of the protein and cloning of its complementary DNA. Biochemistry 28: 8683-8690, 1989.
5. BLAHA J, KOPECKY P, MATIAS M, HOVORKA R, KUNSTYR J, KOTULAK T, LIPS M, RUBES D, STRITESKY M, LINDNER J, SEMRAD M, HALUZIK M: Comparison of three protocols for tight glycemic control in cardiac surgery patients. Diabetes Care 32: 757-761, 2009.
6. BOORD JB, FAZIO S, LINTON MF: Cytoplasmatic fatty acid binding proteins: emerging roles in metabolism and atherosclerosis. Curr Opin Lipidol 13: 141-147, 2002.
7. CABRé A, LáZARO I, GIRONA J, MANZANARES JM, MARIMÓN F, PLANA N, HERAS M, MASANA L: Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes. J Lipid Res 49: 1746-1751, 2008.
8. DOI M, MIYOSHI T, HIROHATA S, NAKAMURA K, USUI S, TAKEDA K, IWAMOTO M, KUSACHI S, KUSANO K, ITO H: Association of increased plasma adipocyte fatty acid-binding protein with coronary artery disease in non-elderly men. Cardiovasc Diabetol 10: 44, 2011.
9. ERBAY E, BABAEV VR, MAYERS JR, MAKOWSKI L, CHARLES KN, SNITOW ME, FAZIO S, WIEST MM, WATKINS SM, LINTON MF, HOTAMISLIGIL GS: Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis. Nat Med 15: 1383-1391, 2009.
10. FINFER S, CHITTOCK DR, SU SY, BLAIR D, FOSTER D, DHINGRA V, BELLOMO R, COOK D, DODEK P, HENDERSON WR, HéBERT PC, HERITIER S, HEYLAND DK, MCARTHUR C, MCDONALD E, MITCHELL I, MYBURGH JA, NORTON R, POTTER J, ROBINSON BG, RONCO JJ: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360: 1283-1297, 2009.
11. FISHER RM, ERIKSSON P, HOFFSTEDT J, HOTAMISLIGIL GS, THöRNE A, RYDéN M, HAMSTEN A, ARNER P: Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals. Diabetologia 44: 1268-1273, 2001.
12. FURUHASHI M, TUNCMAN G, GöRGüN CZ, MAKOWSKI L, ATSUMI G, VAILLANCOURT E, KONO K, BABAEV VR, FAZIO S, LINTON MF, SULSKY R, ROBL JA, PARKER RA, HOTAMISLIGIL GS: Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447: 959-965, 2007.
13. FURUHASHI M, FUCHO R, GöRGüN CZ, TUNCMAN G, CAO H, HOTAMISLIGIL GS: Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration trough actions in both macrophages and adipocytes in mice. J Clin Invest 118: 2640-2650, 2008.
14. HALUZíKOVá D, DOSTáLOVá I, KAVáLKOVá P, ROUBíCEK T, MRáZ M, PAPEZOVá H, HALUZíK M: Serum concentrations of adipocyte fatty acid binding protein in patients with anorexia nervosa. Physiol Res 58: 577-581, 2009.
15. HOTAMISLIGIL GS, JOHNSON RS, DISTEL RJ, ELLIS R, PAPAIOANNOU VE, SPIEGELMAN BM: Uncoupling of obesity from insulin resistance trough a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274: 1377-1379, 1996.
16. HUNT CR, RO JH, DOBSON DE, MIN HY, SPIEGELMAN BM: Adipocyte P2 gene: developmental expression and homology of 5'-flanking sequences among fat cell-specific genes. Proc Natl Acad Sci USA 83: 3786-3790, 1986.
17. KOTULáK T, DRáPALOVá J, KOPECKý P, LACINOVá Z, KRAMáR P, RíHA H, NETUKA I, MALý J, HOUSA D, BLáHA J, SVACINA Š, HALUZíK M: Increased circulating and epicardial adipose tissue mRNA expression of fibroblast growth factor-21 after cardiac surgery: possible role in postoperative inflammatory response and insulin resistance. Physiol Res 60: 757-767, 2011.
18. KREMEN J, DOLINKOVA M, KRAJICKOVA J, BLAHA J, ANDERLOVA K, LACINOVA Z, HALUZIKOVA D, BOSANSKA L, VOKURKA M, SVACINA S, HALUZIK M: Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab 91: 4620-4627, 2006.
19. LAMOUNIER-ZEPTER V, LOOK C, ALVAREZ J, CHRIST T, RAVENS U, SCHUNCK WH, EHRHARTBORNSTEIN M, BORNSTEIN SR, MORANO I: Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res 105: 326-334, 2009.
20. MAKOWSKI L, BOORD JB, MAEDA K, BABAEV VR, UYSAL KT, MORGAN MA, PARKER RA, SUTTLES J, FAZIO S, HOTAMISLIGIL GS, LINTON MF: Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 7: 699-705, 2001.
21. MAKOWSKI L, BRITTINGHAM KC, REYNOLDS JM, SUTTLES J, HOTAMISLIGIL GS: The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor ? and I?B kinase activities. J Biol Chem 280: 12888-12895, 2005.
22. MAZUREK T, ZHANG L, ZALEWSKI A, MANNION JD, DIEHL JT, ARAFAT H, SAROV-BLAT L, O'BRIEN S, KEIPER EA, JOHNSON AG, MARTIN J, GOLDSTEIN BJ, SHI Y: Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108: 2460-2466, 2003.
23. MRAZ M, LACINOVA Z, DRAPALOVA J, HALUZIKOVA D, HORINEK A, MATOULEK M, TRACHTA P, KAVALKOVA P, SVACINA S, HALUZIK M: The effect of very-low-calorie diet on mRNA expression of inflammation-related genes in subcutaneous adipose tissue and peripheral monocytes of obese patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 96: E606-E613, 2011.
24. PELTON PD, ZHOU L, DEMAREST KT, BURRIS TP: PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes. Biochem Biophys Res Commun 261: 456-458, 1999.
25. TöNJES A, KRALISCH S, LöSSNER U, KOVACS P, BLüHER M, STUMVOLL M, FASSHAUER M: Metabolic and genetic predictors of circulating adipocyte fatty acid-binding protein. Int J Obes (Lond) 36: 766-773, 2012.
26. TSO AW, XU A, SHAM PC, WAT NM, WANG Y, FONG CH, CHEUNG BM, JANUS ED, LAM KS: Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care 30: 2667-2672, 2007.
27. TUNCMAN G, ERBAY E, HOM X, DE VIVO I, CAMPOS H, RIMM EB, HOTAMISLIGIL GS: A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. Proc Natl Acad Sci U S A 103: 6970-6975, 2006.
28. UYSAL KT, SCHEJA L, WIESBROCK SM, BONNER-WEIR S, HOTAMISLIGIL GS: Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141: 3388-3396, 2000.
29. VAN DEN BERGHE G: Endocrinology in intensive care medicine: new insights and therapeutic consequences. Verh K Acad Geneeskd Belg 64: 167-187, 2002.
30. VAN DEN BERGHE G, WOUTERS P, WEEKERS F, VERWAEST C, BRUYNINCKX F, SCHETZ M, VLASSELAERS D, FERDINANDE P, LAUWERS P, BOUILLON R: Intensive insulin therapy in the critically ill patients. N Engl J Med 345: 1359-1367, 2001.
31. VON EYNATTEN M, BREITLING LP, ROOS M, BAUMANN M, ROTHENBACHER D, BRENNER H: Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler Thromb Vasc Biol 32: 2327-2335, 2012.
32. XU A, WANG Y, XU JY, STEJSKAL D, TAM S, ZHANG J, WAT NM, WONG WK, LAM KS: Adipocyte fatty acidbinding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem 52: 405-413, 2006.
33. XU A, TSO AW, CHEUNG BM, WANG Y, WAT NM, FONG CH, YEUNG DC, JANUS ED, SHAM PC, LAM KS: Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-years prospective study. Circulation 115: 1537-1543, 2007.